Nucleoprotein Nanostructures Combined with Adjuvants Adapted to the Neonatal Immune Context: A Candidate Mucosal RSV Vaccine

BACKGROUND: The human respiratory syncytial virus (hRSV) is the leading cause of severe bronchiolitis in infants worldwide. The most severe RSV diseases occur between 2 and 6 months-of-age, so pediatric vaccination will have to be started within the first weeks after birth, when the immune system is...

Description complète

Enregistré dans:
Détails bibliographiques
Auteurs principaux: Remot, Aude, Roux, Xavier, Dubuquoy, Catherine, Fix, Jenna, Bouet, Stephan, Moudjou, Mohammed, Eléouët, Jean-François, Riffault, Sabine, Petit-Camurdan, Agnès
Format: Artigo
Langue:Inglês
Publié: Public Library of Science 2012
Sujets:
Research Article
Accès en ligne:https://ncbi.nlm.nih.gov/pmc/articles/PMC3359995/
https://ncbi.nlm.nih.gov/pubmed/22655066
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1371/journal.pone.0037722
Tags: Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!

Documents similaires